Background: The prognostic value of left ventricular (LV) global strain and twist in patients with left bundle branch block (LBBB) is not fully investigated. The aim of this study was to investigate the association between myocardial strain and twist and cardiovascular events in patients with LBBB, as assessed using two-dimensional speckle-tracking echocardiography.
A growing body of evidence suggests that myocardial global strain is a comprehensive indicator of left ventricular (LV) function and also a reliable prognostic factor for cardiovascular events in patients with heart failure (HF). [1] [2] [3] Given the fundamental results of studies performed in patients with HF, the clinical usefulness of LV strain has been investigated in various populations. 4 Left bundle branch block (LBBB) indicates delayed conduction of electrical signals within the ventricular myocardium, occurring from damaged or degenerated left bundle branches. Approximately 30% of patients with HF demonstrate LBBB, and the presence of LBBB is associated with a higher risk for mortality in patients with HF. [5] [6] [7] [8] [9] This can be explained by the pathophysiologic mechanism of LBBB, which in turn contributes to further LV dysfunction. 10, 11 Previous studies have demonstrated that LBBB is associated with deterioration of LV systolic and diastolic function, mainly because delayed ventricular activation leads to a shortened LV filling time and a reduced LV ejection fraction (LVEF), [12] [13] [14] which is the rationale for cardiac resynchronization therapy (CRT).
Measurement of LV global strain can identify subtle myocardial dysfunction even in those with preserved LVEFs. [15] [16] [17] Therefore, it can be suggested that measurement of LV global strain can provide better risk prediction in patients with LBBB than LVEF does. In this study, we assessed the association between global longitudinal strain (GLS) measured by twodimensional (2D) speckle-tracking echocardiography (STE) and the occurrence of cardiovascular events in a cohort of patients with LBBB. The association between LV global strain and cardiovascular events was assessed in relation to LV systolic and diastolic function.
METHODS

Study Population
We retrospectively identified 329 consecutive individuals with LBBB, who underwent 2D echocardiography at Seoul National University Bundang Hospital between July 2009 and August 2015. We excluded those who had undergone heart surgery before the index echocardiographic examination (n = 14) and those with atrial fibrillation (n = 31). We also excluded those with poor image quality for strain measurements (n = 15). Finally, we included 269 patients with LBBB and with adequate image quality for post hoc analysis of strain measurements, including GLS, global circumferential strain (GCS), and twist. Additionally, we selected 77 age-and sex-matched healthy control subjects from a previously established cohort of the Normal Echocardiographic Measurements in Korean Population study. 18 The study was carried out according to the principles of the Declaration of Helsinki and approved by the Clinical Research Institute of Seoul National University Bundang Hospital (L-2016-978) .
Clinical Data
Clinical data on comorbidities were obtained from hospital records. Hypertension was defined as systolic blood pressure $ 140 mm Hg, diastolic blood pressure $ 90 mm Hg, or current use of antihypertensive medications. 19 Diabetes mellitus (DM) was defined as fasting blood glucose $ 126 mg/dL, glycated hemoglobin $ 6.5%, or use of antidiabetic medications. 20 Chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate < 60 mL/min/1.7 3 m 2 , using the 2009 CKD Epidemiology Collaboration creatinine equation. 21 
Echocardiography
All images were obtained with a standard ultrasound machine (Vivid E9; GE Medical Systems, Milwaukee, WI) with a 2.5-MHz probe. Standard techniques were used to obtain M-mode, 2D, and Doppler measurements in accordance with American Society of Echocardiography guidelines. 22, 23 Left atrial dimension was measured in the parasternal long-axis view, and left atrial volume index was measured using a biplane area-length method from the apical four-and two-chamber views and indexed on the basis of body surface area. LV diameter was measured using M-mode imaging. LV end-systolic and end-diastolic volumes and LVEF were calculated using the biplane Simpson method from apical four-and two-chamber views. Mitral E and A peak velocities (cm/s) and deceleration time (msec) were measured. Tissue Doppler-derived peak systolic (s 0 ), early (e 0 ), and late diastolic (a 0 ) velocities were derived from the septal mitral annulus, using color Doppler. Pulmonary artery systolic pressure was estimated by summing the peak systolic transtricuspid pressure gradient calculated from the peak velocity of tricuspid regurgitation and right atrial pressure estimated by the diameter and inspiratory collapsibility of the inferior vena cava (IVC). According to current guidelines, 22 the right atrial pressure was estimated as 3 mm Hg in patients with IVC diameter < 2.1 cm that collapsed >50% with sniffing, 8 mm Hg in those with IVC diameter > 2.1 cm that collapsed > 50% and in those with IVC diameter < 2.1 cm that collapsed <50%, and 15 mm Hg in those with IVC diameter > 2.1 cm that collapsed <50%. Among the total study population, pulmonary artery systolic pressure values were available in 210 patients (78.1%).
Follow-up echocardiography was performed in 124 patients at a $6-month interval to obtain LV diameter using M-mode imaging and LV end-systolic and end-diastolic volumes with LVEF using the biplane Simpson method.
Strain Analysis
We used 2D echocardiographic images of study participants for post hoc strain analysis. All echocardiograms were analyzed in a blinded fashion by an independent core laboratory (Seoul National University Bundang Hospital) according to current guidelines and recommendations. 22, 24 As a routine protocol followed by our laboratory, echocardiographic images for deformation analyses were recorded at a frame rate of 60 frames/sec (with individual adjustment between 50 and 70 frames/sec) for two cardiac cycles. Recordings were processed with acoustic-tracking software (EchoPAC BT12; GE Medical Systems, Milwaukee, WI), allowing offline semiautomated speckle-based strain analyses.
For global 2D strain analysis, a digital loop was acquired from three parasternal short-axis views (at the apical, midpapillary, and basal level) and three apical views (four-, two-, and three-chamber views). All images were transferred to network-attached storage and analyzed offline. We traced along the LV endocardial border at the end-systolic frame. The strain curve was extracted from grayscale images using dedicated software (EchoPAC BT12). We calculated the global strain values by averaging the values computed at the segmental level, as recommended in the consensus document of the American Society of Echocardiography and the European Association of Cardiovascular Imaging, 24 and obtained GLS and GCS from three standard apical views and short-axis view at midpapillary level, respectively ( Figure 1 ). For measurement of LV twist, we used the difference in rotation between cardiac apex and base: the basal level was marked as one showing the tips of mitral valve leaflets and the apical level as just proximal to the level with LV luminal obliteration at the end-systolic period.
Two specialists (G.-Y.C. and I.-C.H.) reviewed the echocardiographic images for measurement of LV global strain values. We randomly selected 20 patients from our study, and intraobserver and interobserver variabilities were analyzed from the randomly selected 20 patients, using Pearson's correlation coefficient (r), the intraclass correlation coefficient, and Bland-Altman statistics (Table 1 , Supplementary Figure S1 , available at www.onlinejase.com). 
Outcome Measure
Our study population was followed up until August 2016. The study end point was a composite of the occurrence of cardiovascular mortality and hospitalization for HF during follow-up. Cardiovascular mortality was defined as death due to HF, acute coronary syndrome, fatal arrhythmia, stroke, or sudden cardiac death and was verified from hospital records or death certificates from primary doctors. Hospitalization for HF was defined as admission for worsening signs or symptoms of HF requiring intravenous diuretics or vasodilators and was verified from hospital records. If a patient experienced multiple events among the composite, only the first event was counted. If a patient underwent CRT, the patient was censored at the time of admission for device implantation and was neither deleted from the study population nor counted as having had an event.
Statistical Analysis
Categorical variables are presented as frequencies and percentages and continuous variables as mean 6 SD or median (interquartile range). For the normality test, we used the Kolmogorov-Smirnov test: variables with P values < .50 were considered as having nonparametric distribution and variables with P values $ .50 as having parametric (normal) distribution. Group comparisons were performed using Student's t test, the matched-pair t test, or the Mann-Whitney U test. The c 2 test or the Fisher exact test was used for categorical variables. Multicollinearity was assessed by computing the variance inflation factor. The cutoff values for GLS, GCS, and twist were set according to receiver operating characteristic (ROC) curve analysis, and the value showing the maximum likelihood ratio on the curve was established as the cutoff point. The cutoff value for LVEF was determined primarily from current clinical guidelines, 25 as well as the results of ROC curve analysis. For survival analysis, the hazard ratios (HRs) for the composite end point were calculated among the baseline demographic factors, echocardiographic parameters, and LV global strain measurements, using the Kaplan-Meier method with the log-rank test and the univariate Cox proportional hazard model for comparison of time to the event. Multivariate Cox proportional hazard model analysis was used for univariate markers with P values < .10. Because of the relatively small number of events, we used stepwise backward elimination methods to select factors for inclusion in the multivariate analysis (inclusion criterion, P < .05; exclusion criterion, P > .10). Additionally, the adjusted HRs for composite end points were calculated across the subgroups stratified by the levels of strain measurements and LVEF (35% and 40%).
All statistical analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC) and SPSS version 20.0 (SPSS, Chicago, IL), and P value < .05 was considered to indicate statistical significance. Table 2 shows the baseline characteristics of the study population, divided according to the occurrence of the composite end point. The mean age was 69.5 6 10.9 years, and 46.8% were men. During a median of 27.5 months (interquartile range, 12.8-43.9 months) of follow-up, 55 patients (20.4%) had composite end points, including cardiovascular mortality (n = 12 [4.5%]) and hospitalization for HF (n = 51 [19.0%]). Twenty-nine patients (10.8%) underwent CRT during follow-up, and these patients were censored at the time of the procedure and regarded as not having had clinical events. Presence of DM, CKD, ischemic etiology of LBBB, and use of cardiovascular preventive medications were significantly more prevalent among those who had had composite end points. Mean QRS duration was not different between the subgroups.
RESULTS
Baseline Characteristics
Echocardiographic Parameters and Strain Measurements
Echocardiographic parameters showed significant differences between patients without clinical events and those who had clinical events (Table 3) . Among the group with poor prognosis, LV cavity size was larger, LVEF was lower (48.4 6 13.8% vs 29.5 6 13.9%, Figure 1 Representative figures of global strain and twist measurements using 2D STE. (A) LV GLS was calculated from three standard apical views with corresponding time-strain curves from 18 segments. (B) LV GCS was obtained from short-axis view at the midpapillary level, and (C) twist value was calculated as the net difference between LV peak rotation angles from basal and apical parasternal short-axis views (white arrow). P < .001), and LV diastolic function was more severely impaired (E/e 0 ratio 14.3 6 7.1 vs 22.3 6 11.6, P = .001). Of note, 85.5% of patients (47 of 55) who had had clinical events showed LVEFs < 40%.
LV strain parameters were measured by 2D speckle-tracking. Intraobserver and interobserver variabilities for our laboratory, obtained from 20 randomly selected patients among our study population, are summarized in Table 1 and Supplementary Figure S1 (available at www.onlinejase.com). The intraclass correlation coefficients for GLS, GCS, and twist measurements were 0.987, 0.948, and 0.917 for intraobserver variation and 0.978, 0.947, and 0.920 for interobserver variation. Bland-Altman plots demonstrated the following limits of agreement (LOA) across a broad range of GLS: the bias for intraobserver measurements of GLS was 0.5% with a range in strain values of À1.6% to +2.6% (95% LOA), and the bias for interobserver measurements of GLS was 0.5% with a range in strain values of À2.1% to +3.1% (95% LOA). The bias for intraobserver measurements of GCS was 1.1% (95% LOA, À2.9% to +5.1%), and the bias for interobserver measurements of GCS was À1.0% (95% LOA, À4.8% to +2.8%). The bias for twist measurements was 2.1% (95% LOA, À3.5% to 7.7%) for intraobserver measurements and was À1.5% (95% LOA, À6.6% to 3.6%) for interobserver measurements.
In our study population, the mean values of GLS, GCS, and twist were À13.5 6 4.6%, À12.8 6 4.8%, and 10.1 6 6.9
, respectively. GLS was significantly impaired among those who had clinical events during follow-up (À14.8 6 4.0% vs À8.7 6 3.9%, P < .001). Similarly, patients with composite end points had significantly impaired GCS (À13.7 6 4.6% vs À9.0 6 3.9%, P < .001) and twist (10.8 6 7.1 vs 7.1 6 5.0 , P < .001). Compared with age-and sex-matched healthy control subjects, the study population had significantly larger LV size and poorer LV function (Supplementary Table S1 , available at www.onlinejase.com): the mean LVEF was 44.5 6 15.8% in patients with LBBB and 63.1 6 4.0% in healthy control subjects (P < .001), and the mean GLS was À13.5 6 4.6% in patients with LBBB and À20.7 6 2.4% in healthy control subjects (P < .001).
Association of Global Function with Cardiovascular Events in Patients with LBBB
ROC analyses showed the cutoff values of strain measurements for the composite end point: À12.2% for GLS, À11.8% for GCS, and 6.5 of twist ( Figure 2 ). The cutoff value of LVEF by ROC curve analysis was 39.8% and was substituted with 40% and 35% considering current clinical guidelines. 25 Impaired GLS (>À12.2%) showed significant association with the occurrence of cardiovascular mortality and hospitalization for HF (adjusted HR, 4.697; 95% CI, 1.344-16.413; P = .015), even after adjusting for univariate risk factors such as presence of DM, CKD, ischemic etiology of LBBB, and echocardiographic parameters such as left atrial volume index, LV cavity size, and LVEF, using the stepwise backward elimination method ( Figure 3A , Tables 4 and 5 ). However, impaired GCS (>À11.8%) and twist (<6.5
) were not significantly associated with the composite end point (Figures 3B and 3C, Table 5 ).
Additive Association of GLS on Cardiovascular Risk
Given that LVEF is a well-established prognostic marker, we assessed the associations between GLS and the occurrence of cardiovascular events in subgroups on the basis of an LVEF value of 40% (Figures 4 and 5). Among patients with preserved LVEFs ($40%), those with impaired GLS had a significantly higher event rate (annual event rate 11.9% for those with GLS >À12.2% vs 1.1% for those with GLS ICC, Intraclass correlation coefficient. Data are expressed as mean 6 SD. Intraobserver and interobserver variability was assessed by reviewing the echocardiographic images of 20 randomly selected patients from the study.
One specialist (G. #À12.2%, P = .002). Impaired GLS showed a significant association with poor outcomes even in those with depressed LV systolic function as measured by LVEF < 40% (annual event rate 30.8% for those with GLS >À12.2% vs 8.1% for those with GLS #À12.2%, P = .018). Risk for the composite end point among patients with preserved LVEFs ($40%) but impaired GLS (>À12.2%) was numerically higher than those with impaired LVEFs but preserved GLS (annual event rate 11.9% vs 8.1%). When the subgroups were classified on the basis of an LVEF of 35%, the higher risk for the composite end point among patients with preserved LVEFs ($35%) but impaired GLS (>À12.2%) than those with impaired LVEFs but preserved GLS became more apparent (annual event rate 23.0% vs 8.1%; Supplementary Figures S2 and S3, available at www. onlinejase.com).
The association between GLS and cardiovascular events was also evaluated using the global c 2 test (Figure 6 ). When the significant univariate factors, including the presence of DM, CKD, ischemic etiology of LBBB, and cardiac chamber sizes (left atrial volume index and LV end-diastolic diameter) were used, the global c 2 for the occurrence of the composite end point was 60.886 (model 1). In model 2, in which the LVEF was added to model 1, the global c 2 increased to 76.195 (P < .001 vs model 1). The addition of GLS significantly increased the overall association with the occurrence of cardiovascular events when added to model 1 (model 3; global c 2 = 85.941, P < .001 vs model 1). Of note, the addition of GLS to model 2 significantly increased the association with the composite end point (model 4; global c 2 = 90.543, P = .002 vs model 2), but the addition of LVEF to model 3 did not (P = .104 vs model 3), suggesting the significant incremental prognostic value of GLS when added to LVEF measurement.
Changes in LV Function and Cardiovascular Events
Among our study population, 124 patients (91 patients without composite end points and 33 patients with composite end points during follow-up) underwent repeat echocardiographic examination with a $6-month interval (median, 24.1 months; interquartile range, 13.3-42.3 months; Supplementary Table S2, available at www. onlinejase.com). LVEF showed a significant increase at the time of the follow-up examination among patients with LBBB without composite end points (44.2 6 14.7% at baseline, 48.1 6 13.1% at followup; P = .001 by paired t test) but did not change among those who had had clinical events (30.2 6 15.9% at baseline, 25.7 6 12.6% at followup; P = .204 by paired t test; Supplementary Figure S4A , available at www.onlinejase.com). However, the GLS value did not change among those without clinical events (À13.7 6 4.2% at baseline, À13.9 6 4.2% at follow-up; P = .711 by paired t test) but showed significant deterioration among those with clinical events (À9.5 6 4.3% at baseline, À7.6 6 4.0% at follow-up; P = .003 by paired t test; Supplementary Figure S4B , available at www.onlinejase.com). Patients who underwent CRT were censored at the time of procedure and were considered as not having the composite end point. ‡
Composite end point was defined as the first occurrence of cardiovascular mortality or hospitalization for HF.
We also performed a Cox proportional hazard regression analysis in those who had follow-up echocardiographic measurements (Supplementary Table S3 , available at www.onlinejase.com). The presence of DM and further impairment of GLS noted on followup echocardiography showed significant associations with the occurrence of composite end point (DM: adjusted HR, 2.649 [95% CI, 1.178-5.958; P = .018]; impairment of GLS: adjusted HR, 8.002 [95% CI, 2.895-22.118; P < .001]). However, the decrease in LVEF was not significantly associated with clinical events.
DISCUSSION
We showed that impaired LV GLS measured by 2D STE has a significant and independent association with the occurrence of cardiovascular events in patients with LBBB. The association between impaired GLS and higher cardiovascular risk was significant in both subgroups: those with reduced and those with preserved LVEFs. Furthermore, the addition of GLS to clinical risk factors and other echocardiographic parameters resulted in a significant improvement in the association between clinical risk factors and cardiovascular events than that of LVEF. These results suggest that measurement of LV GLS can provide better risk stratification than LVEF in patients with LBBB and may contribute to better decision making for further treatment in this population.
Risk Stratification in Patients with LBBB: Limitations of LVEF
According to epidemiologic studies, the prevalence of LBBB ranges from 0.1% to 0.9% in the general population and increases significantly in those with advanced age or with HF: LBBB was found in 2.2% among individuals aged $55 years, in 5.7% among individuals at 80 years of age, and in 25% to 30% among patients with HF. [5] [6] [7] [8] 26, 27 It is not uncommon to regard patients with LBBB and preserved systolic function as a low-risk group, in whom further treatment is not an immediate requirement. However, the presence of LBBB is associated with higher risk for cardiovascular events and mortality, mainly because of the increased risk for sudden cardiac death from fatal arrhythmia and the detrimental hemodynamic influence from LBBB. [10] [11] [12] [13] [14] Given the impacts of LBBB on the risk for mortality and hemodynamic deterioration, accurate risk assessment and recognition of LV dysfunction are essential. However, the most commonly used parameter of LV systolic function, LVEF, has important limitations, especially among patients with LBBB. LVEF uses geometric changes in LV dimensions and volumes and is an indirect method to reflect LV function rather than the intrinsic myocardial contractility, which LV GLS measures. In patients with LBBB, dyssynchronous LV motion with earlier activation of the septal wall than the lateral wall can lead to underestimation of true LV function using LVEF as a tool for assessment. Moreover, volumetric LVEF measurement in patients with LBBB might be inaccurate, because the basic assumptions of the biplane Simpson method that regard the LV cavity as a truncated ellipsoid and symmetrically shaped structure are not applicable in this population with dyssynchronous LV contraction.
Early Recognition of LV Dysfunction by Global Strain in Patients with LBBB
In the present study, we demonstrated that LV GLS has a more significant association with the occurrence of cardiovascular events than LVEF among patients with LBBB. The stronger association of GLS with cardiovascular risk compared with LVEF seems to be related to the aforementioned limitations of LVEF in this population as well as the nature of strain measurements. It is well established that LVEF is more dependent on loading conditions than LV global strain and relatively insensitive to subtle abnormalities of LV function. 28, 29 Although LV global strain is also known to be load dependent, previous studies have shown that myocardial global strain may be a more sensitive indicator of ventricular dysfunction, its predictive ability extending beyond LVEF, and this expectation has been confirmed in various populations with various diseases, even among those with preserved LVEFs.
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Noteworthy in our results was that among the measurements of LV global function, GLS showed a significant association with cardiovascular events, but GCS and twist values did not. The greater utility of GLS in reflecting subtle LV dysfunction and earlier prediction of poor prognosis in preclinical disease can be explained by a pathophysiologic background as follows: GLS reflects the contraction of the subendocardial layer, which is mainly longitudinally oriented, whereas GCS and twist values may be less sensitive in detecting subtle myocardial dysfunction that originates in the subendocardial layer. 28, 31, 32 These values can detect more advanced diseases affecting the midwall and subepicardial myocardial fibers. According to a case-control study of patients with HF, GLS was reduced but GCS and twist were normal in patients with HF and preserved LVEFs. 33 Those results show that impaired subendocardial function can be reflected by reduced GLS values, whereas the midwall and subepicardial myocardium are affected by further progressive pathologic changes. Our findings also support this pathophysiology, noting that impaired GLS had a significant association with cardiovascular events even in those with preserved LVEFs. Additionally, it should be noted that the basal portion of the ventricle is connected with longitudinal subendocardial muscle fibers sensitive to ischemia, and other measures of strain and even LVEF are not sufficiently sensitive to detect minor ventricular changes in the basal portions, which display the highest velocities within the heart. 34 
Clinical Perspectives: Global Strain in Patients with LBBB
In the present study, we showed that impaired GLS had a significant association with the composite end point not only among patients with reduced LVEFs (<40%) but also among those with LVEFs $40% (Figures 3 and 4) . This partition value of LVEF 40% was obtained from the ROC curve analysis, and the patients with LBBB with LVEFs $40% may further indicate those with ''preserved LVEFs,'' as LVEF can be underestimated in a dyssynchronous left Figure 2 ROC analysis with area under the curve, 95% CI, and P values shown for GLS (red), GCS (orange), twist (green), and LVEF (blue). The cutoff points were determined at each value showing the maximum likelihood ratio in the curve. Figure 3 Risk-adjusted event-free survival curves according to global strain and twist. Cumulative incidence curves are shown for the composite end point of all-cause mortality and hospitalization for heart failure, according to GLS (A), GCS (B), and twist (C). P values were obtained from multivariate Cox proportional-hazards model analysis with the significant univariate predictors among the clinical risk factors and echocardiographic parameters, using the stepwise backward elimination method.
ventricle. These findings emphasize the clinical usefulness of LV GLS in patients with LBBB, given that a significant proportion of patients with LBBB have normal or preserved LVEFs 35 and that >60% of patients in our cohort had LVEFs $40%. In real-world practice, this discrepancy between the presence of LBBB and preserved LVEF affects risk prediction in patients with LBBB with subclinical LV dysfunction. Considering the potential relationship between LV dyssynchrony and further deterioration of LV function, 10,11 a more sensitive parameter to detect subtle LV dysfunction is required in patients with LBBB.
It should be noted that LV GLS was a more sensitive and significant predictor of cardiovascular events than LVEF among patients with LBBB, and the association between impaired LV GLS and poor clinical outcomes remained independent and significant even among those with preserved LVEFs in our present study. Our findings agree with the previous reports that showed limitations of LVEF in recognition of subtle myocardial dysfunction at an earlier stage of the disease process, regardless of disease type 15, 17 and also suggest that the GLS assessed by 2D STE can be a good additive and potentially alternative measure for better risk stratification than LVEF. Moreover, our subgroup analysis demonstrated that patients who had experienced cardiovascular events showed further deterioration of GLS during follow-up and that the deterioration of GLS has a significant and independent association with the occurrence of cardiovascular events. Although we could not provide the detailed hemodynamic impacts of LBBB to the deterioration of LV function in this study, our results are concordant with previous studies, supporting the independent contribution of LBBB to poor prognosis. [10] [11] [12] 14 On the basis of these findings, we suggest that if patients with LBBB have impaired LV strain, strict clinical vigilance is necessary, as these patients may undergo rapid deterioration and poor prognosis, even among those with preserved LVEF.
The stronger association of LV GLS with cardiovascular events than that of LVEF in patients with LBBB not only indicates that the assessment of GLS is a very helpful measure for risk prediction but also suggests that it can be further incorporated in clinical decision making. In particular, the additional findings based on an LVEF partition value of 35%, as provided in the supplementary materials (Supplementary Figures S2 and S3 , available at www.onlinejase. com), have implications for the current clinical guidelines for the advanced medical and device therapies for patients with poor LV function. Among patients with LBBB and poor LV function, CRT can be a good treatment option, as it restores cardiac dyssynchrony and improves LV function and clinical outcomes. [36] [37] [38] A recent study by Delgado-Montero et al 39 showed that LV global strain has an additive prognostic value for long-term outcomes after CRT in patients with HF and LBBB. In addition to the higher sensitivity shown by LV global strain for the detection of myocardial dysfunction, compared with LVEF, adding GLS measurement as a parameter to clinical and echocardiographic risk factors would improve the prediction of future cardiovascular events and assist with selection of candidates for CRT. Although it is not yet clear whether intensified medical therapy and CRT lead to clinical benefits in patients with LBBB and impaired GLS, our study supports the possibility that LV GLS may prove useful to identify candidates for CRTwho currently have LVEFs >35%. Future clinical trials would be needed to assess the potential role of LV global strain measurements in the selection of candidates for CRT and in prediction of post-CRT outcomes, compared with LVEF.
Notably, strain measurement can be performed after echocardiographic examination using specialized acoustic-tracking software. If considerable benefit is noted to be derived from LV strain measurements allowing intensification of medical therapy as well as greater application of CRT, the clinical application of strain measurement could be regarded as a reasonable and effective prognostic method. Therefore, future research should consider the long-term benefits of GLS and other strain measurements in relation with intensified treatment strategies, as well as with the effort and time spent by medical staff.
Limitations
This study was subject to the following limitations. First, participants were studied retrospectively and consisted of those who were referred for echocardiographic examination. Also, strain measurement were performed on previously obtained echocardiographic results using acoustic-tracking software. Although these may limit our main messages to hypothesis-generating results because of potential referral bias, we do consider that our study reflects real-world practice and that our method emphasizes the clinical feasibility and applicability of strain measurement. Figure 4 Risk-adjusted event-free survival according to LVEF and GLS. Event-free survival curves for the composite end point are demonstrated according to the levels of LVEF (40%) and GLS (À12.2%), adjusted for significant univariate predictors such as the presence of diabetes, chronic kidney disease, ischemic etiology of LBBB, and echocardiographic parameters such as left atrial volume index and LV end-diastolic dimension, using the stepwise backward elimination method. , or per 1 mL/m 2 increase), LVEF (cutoff value of 40%, or per 1% decrease), and LV GLS (cutoff value of À12.2%, or per 1% impairment) using the stepwise backward elimination method: impaired LV GLS and the presence of CKD were significant factors associated with the occurrence of cardiovascular death and HF hospitalization. †
In the multivariate analysis with the presence of DM, CKD, ischemic etiology of LBBB, LV end-diastolic diameter, left atrial volume index, LVEF and LV GCS (cutoff value of À11.8%, or per 1% impairment), the impaired LV GCS was not significantly associated with the cardiovascular events, whereas impaired LVEF was a significant factor.
Second, we could not provide data on the symptomatic status of the studied patients, which is an indication for CRT. There were 29 patients who underwent CRT during the study period. Although patients who underwent CRT or those who were candidates for CRT might have influenced the overall predictive ability for the occurrence of cardiovascular events, our main findings would not be grossly altered because most recipients of CRT had poor LVEFs, as well as impaired global strain.
Third, although we demonstrated consistent results supporting the independent prognostic value of LV GLS using several statistical analyses, the possibility of overfitting may exist because of the small sample size and the small number of events. Further studies involving more patients and a sufficient duration of follow-up to capture a larger number of cardiovascular events are warranted to investigate the impact of strain measurements on the long-term prognosis of patients with LBBB.
Fourth, we could not investigate whether medications can affect strain measurements in terms of altering hemodynamics, as well as myocardial remodeling. Although it is known that strain measurements are relatively independent of loading conditions, the role of hemodynamic changes in strain measurements by renin-angiotensinaldosterone system blockers would be an important clinical issue, considering the antiremodeling effect of this class of medication.
Fifth, biomarkers of myocardial function or neurohormonal activation, such as troponin and natriuretic peptide, were not available.
Sixth, given the non-negligible intervendor differences in strain measurements, generalization of our findings to other vendors should be undertaken with caution.
CONCLUSIONS
LV GLS assessed by 2D STE had a significant association with cardiovascular events in patients with LBBB. The association of GLS with cardiovascular events was more significant compared with LVEF and was noted to be significant in both subgroups of patients with reduced and preserved LVEFs. Our findings suggest the potential of GLS measurement for risk stratification in patients with LBBB.
SUPPLEMENTARY DATA
Supplementary data related to this article can be found at https://doi. org/10.1016/j.echo.2017.08.016. Annual event rates according to LVEF and GLS. Annual rates of the composite end point were compared between subgroups divided by the levels of LVEF (40%) and GLS (À12.2%). P values were obtained from multivariate Cox proportionalhazards models with the significant univariate predictors as covariates, using the stepwise backward elimination method.
Supplementary Figure S1 Intraobserver and interobserver variability. Scatterplots and Bland-Altman plots are shown for LV GLS measurements in the top row, LV GCS measurements in middle row, and twist measurements in the bottom row. Pearson correlation coefficient (r), intraclass correlation coefficient (ICC), and Bland-Altman bias with LOA are provided for intraobserver variability (left two columns) and for interobserver variability (right two columns).
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Supplementary Figure S2 Risk-adjusted event-free survival according to LVEF (35%) and GLS (À12.2%). Risk-adjusted event-free survival curves for the composite end point are demonstrated according to the levels of LVEF and GLS, using the significant univariate predictors as covariates in multivariate Cox proportional-hazards models. Figure S3 Annual event rates according to LVEF (35%) and GLS (À12.2%). Annual rates of the composite of cardiovascular mortality and hospitalization for heart failure were compared between subgroups divided according to LVEF (35%) and GLS (À12.2%). P values were obtained from multivariate Cox proportional-hazards models with stepwise backward elimination, using significant univariate predictors as covariates. 
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